Symbicort Onset of Action 1

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-04-30

Study Completion Date

2003-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the early onset of effect of Symbicort compared to Advair Diskus and Ventolin in adults with asthma

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Symbicort Onset of Action 2

NCT00646009

Asthma

COMPLETED PHASE3

A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®

NCT00244608

Asthma

COMPLETED PHASE3

Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM

NCT00652392

Asthma

COMPLETED PHASE3

Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler

NCT00658255

Stable Asthma

COMPLETED PHASE2

Effect of Symbicort on GR Localisation in Asthma

NCT00159263

Asthma

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

budesonide/formoterol

Group Type EXPERIMENTAL

budesonide/formoterol (Symbicort)

Intervention Type DRUG

2

fluticasone/salmeterol

Group Type ACTIVE_COMPARATOR

fluticasone/salmeterol (Advair Diskus)

Intervention Type DRUG

3

albuterol

Group Type ACTIVE_COMPARATOR

albuterol (Ventolin)

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

budesonide/formoterol (Symbicort)

Intervention Type DRUG

fluticasone/salmeterol (Advair Diskus)

Intervention Type DRUG

albuterol (Ventolin)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Symbicort Advair Diskus Ventolin

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of asthma and baseline lung function test results as determined by protocol
* Required and received asthma maintenance therapy within previous 4 weeks at doses determined by protocol

Exclusion Criteria

* Severe asthma or asthma markedly affected by seasonal factors
* Has required treatment with any non-inhaled corticosteroids within previous 4 weeks, has sensitivity to drugs specified in the protocol or requires treatment with beta-blockers

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No